IT1105040B - 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati - Google Patents

3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati

Info

Publication number
IT1105040B
IT1105040B IT49523/78A IT4952378A IT1105040B IT 1105040 B IT1105040 B IT 1105040B IT 49523/78 A IT49523/78 A IT 49523/78A IT 4952378 A IT4952378 A IT 4952378A IT 1105040 B IT1105040 B IT 1105040B
Authority
IT
Italy
Prior art keywords
pirido
pirimidin
oni
tetrazol
replaced
Prior art date
Application number
IT49523/78A
Other languages
English (en)
Other versions
IT7849523A0 (it
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT7849523A0 publication Critical patent/IT7849523A0/it
Application granted granted Critical
Publication of IT1105040B publication Critical patent/IT1105040B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
IT49523/78A 1977-05-25 1978-05-24 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati IT1105040B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/800,264 US4122274A (en) 1977-05-25 1977-05-25 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Publications (2)

Publication Number Publication Date
IT7849523A0 IT7849523A0 (it) 1978-05-24
IT1105040B true IT1105040B (it) 1985-10-28

Family

ID=25177928

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49523/78A IT1105040B (it) 1977-05-25 1978-05-24 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati

Country Status (26)

Country Link
US (1) US4122274A (it)
JP (1) JPS6050197B2 (it)
AT (1) AT365187B (it)
AU (1) AU521211B2 (it)
BE (1) BE867295A (it)
CA (1) CA1098520A (it)
CH (1) CH642656A5 (it)
CY (1) CY1218A (it)
DE (1) DE2822544A1 (it)
DK (1) DK160279C (it)
FI (1) FI64594C (it)
FR (1) FR2401159A1 (it)
GB (1) GB1596476A (it)
GR (1) GR71887B (it)
HK (1) HK25884A (it)
IE (1) IE46849B1 (it)
IT (1) IT1105040B (it)
KE (1) KE3357A (it)
LU (1) LU79694A1 (it)
MY (1) MY8500305A (it)
NL (1) NL190702C (it)
NO (1) NO150361C (it)
SE (1) SE437830B (it)
SG (1) SG73383G (it)
YU (2) YU42163B (it)
ZA (1) ZA782816B (it)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495189A (en) * 1975-11-27 1985-01-22 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Condensed pyrimidines
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
HU180439B (en) * 1977-12-29 1983-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives
US4192944A (en) * 1978-04-03 1980-03-11 Bristol-Myers Company Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4491587A (en) * 1978-05-05 1985-01-01 Mead Johnson & Company Tetrazole derivatives
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones
US4282360A (en) * 1979-10-12 1981-08-04 Hoffmann-La Roche Inc. 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
US4507477A (en) * 1982-09-09 1985-03-26 Riker Laboratories, Inc. Process for tetrazolyl-pyrimidinone derivatives
US4474953A (en) * 1982-09-09 1984-10-02 Riker Laboratories, Inc. Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
CA1283411C (en) * 1985-09-25 1991-04-23 Masami Doteuchi 9-(substituted thio)-4h-pyrido[1,2-a]-pyrimidin-4-one derivatives
JPS63183581A (ja) * 1985-10-03 1988-07-28 Tokyo Tanabe Co Ltd ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬
JPS62242682A (ja) * 1986-04-16 1987-10-23 Tokyo Tanabe Co Ltd 新規なピリド［１，２―ａ］ピリミジン誘導体及びその製造法
JP2504788B2 (ja) * 1987-11-10 1996-06-05 東京田辺製薬株式会社 ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤
EP0348527B1 (en) * 1987-12-25 1993-06-23 Santen Pharmaceutical Co., Ltd. Antiallergic eye drop
CA2010336C (en) * 1989-02-27 1996-11-19 Atsunori Sano Process for producing pyrido[1,2-a]pyrimidine derivative
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
AU674016B2 (en) 1992-07-30 1996-12-05 Mitsubishi-Tokyo Pharmaceuticals, Inc. Remedy for inflammatory intestinal diseases
US5527802A (en) * 1992-10-01 1996-06-18 Bristol-Myers Squibb Company New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
JPH0892093A (ja) * 1994-11-10 1996-04-09 Tokyo Tanabe Co Ltd ９−メチル−３−（１Ｈ−テトラゾール−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンの水性製剤
WO2002072580A1 (fr) * 2001-02-26 2002-09-19 Mitsubishi Pharma Corporation Preventifs et/ou remedes contres des maladies renales et l'insuffisance renale
ITMI20011764A1 (it) 2001-08-10 2003-02-10 Dinamite Dipharma Spa Metodo per l'ottenimento del pemirolast ad elevata purezza
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
CA2672976A1 (en) * 2006-12-18 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
ES2395120T3 (es) * 2006-12-20 2013-02-08 Cardoz Ab Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios
WO2009007679A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
EP2175845A2 (en) * 2007-07-11 2010-04-21 Cardoz AB New combination for use in the treatment of inflammatory disorders
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
US20110092463A1 (en) * 2008-04-07 2011-04-21 Johan Raud Combination for use in the treatment of inflammatory disorders
EP3141549A1 (en) * 2009-06-16 2017-03-15 RSPR Pharma AB Crystalline form of pemirolast for use in the treatment of inflammations
USD661900S1 (en) 2010-02-22 2012-06-19 Bajer Design & Marketing, Inc. Collapsible structure
DK2812004T3 (en) 2012-02-10 2018-10-15 Ptc Therapeutics Inc COMPOUNDS FOR TREATMENT OF SPINAL MUSCLE DROPHY
KR102099997B1 (ko) 2012-03-01 2020-04-13 피티씨 테라퓨틱스, 인크. 척수성 근위축증을 치료하기 위한 화합물
US9914722B2 (en) 2012-03-23 2018-03-13 Ptc Therapeutics, Inc. Compounds for treating spinal muscular atrophy
EP3082820B1 (en) 2013-12-19 2022-07-20 PTC Therapeutics, Inc. Methods for modulating the amount of rna transcripts
US20160243122A1 (en) 2014-10-23 2016-08-25 Rspr Pharma Ab Use of pemirolast in the treatment of acute asthma
WO2016102941A1 (en) 2014-12-22 2016-06-30 Rspr Pharma Ab New combination of pemirolast and montelukast
EP3298017B1 (en) * 2015-05-20 2019-08-14 H. Hoffnabb-La Roche Ag Compounds for treating spinal muscular atrophy
EP3310169B1 (en) 2015-05-30 2023-05-17 PTC Therapeutics, Inc. Methods for modulating rna splicing
GB201518831D0 (en) 2015-10-23 2015-12-09 Rspr Pharma Ab New use
ES2879995T3 (es) 2015-12-10 2021-11-23 Ptc Therapeutics Inc Métodos para el tratamiento de la enfermedad de Huntington
GB201601138D0 (en) * 2016-01-21 2016-03-09 Rspr Pharma Ab New use
WO2018098446A1 (en) 2016-11-28 2018-05-31 Ptc Therapeutics, Inc Methods for modulating rna splicing
AU2018282154B2 (en) 2017-06-05 2022-04-07 Ptc Therapeutics, Inc. Compounds for treating huntington's disease
EA202090034A1 (ru) 2017-06-14 2020-04-16 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы модификации сплайсинга рнк
BR112019027719A2 (pt) 2017-06-28 2020-07-28 Ptc Therapeutics, Inc. métodos para tratar a doença de huntington
WO2019005980A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
KR20210005559A (ko) 2018-03-27 2021-01-14 피티씨 테라퓨틱스, 인크. 헌팅턴병 치료 화합물
AU2019294478B2 (en) 2018-06-27 2023-03-23 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072485A (en) * 1960-08-24 1963-01-08 Eastman Kodak Co Optically sensitized azido polymers for photomechanical resist compositions
AT299212B (de) * 1966-11-02 1972-06-12 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen
US3960847A (en) * 1972-04-17 1976-06-01 E. R. Squibb & Sons, Inc. 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
US4012387A (en) * 1975-09-18 1977-03-15 Warner-Lambert Company Benzo-[g]pyrido[2,1-b]quinazolinones

Also Published As

Publication number Publication date
FI64594B (fi) 1983-08-31
HK25884A (en) 1984-03-30
NL7805534A (nl) 1978-11-28
FI781614A (fi) 1978-11-26
YU233082A (en) 1988-08-31
NO781786L (no) 1978-11-28
AU521211B2 (en) 1982-03-25
GR71887B (it) 1983-08-04
IT7849523A0 (it) 1978-05-24
SG73383G (en) 1984-08-03
YU123678A (en) 1983-02-28
NO150361C (no) 1984-10-03
AU3631978A (en) 1979-11-29
NL190702B (nl) 1994-02-01
FR2401159A1 (fr) 1979-03-23
JPS6050197B2 (ja) 1985-11-07
SE7805954L (sv) 1978-11-26
DE2822544A1 (de) 1978-12-07
DE2822544C2 (it) 1988-10-27
AT365187B (de) 1981-12-28
DK160279C (da) 1991-07-22
YU42163B (en) 1988-06-30
KE3357A (en) 1984-02-03
ATA373278A (de) 1981-05-15
CH642656A5 (de) 1984-04-30
ZA782816B (en) 1979-05-30
GB1596476A (en) 1981-08-26
BE867295A (fr) 1978-11-20
DK228878A (da) 1978-11-26
DK160279B (da) 1991-02-18
IE46849B1 (en) 1983-10-05
MY8500305A (en) 1985-12-31
FR2401159B1 (it) 1983-05-20
US4122274A (en) 1978-10-24
IE781036L (en) 1978-11-25
NO150361B (no) 1984-06-25
JPS5436294A (en) 1979-03-16
LU79694A1 (fr) 1979-02-02
NL190702C (nl) 1994-07-01
CA1098520A (en) 1981-03-31
CY1218A (en) 1984-04-06
SE437830B (sv) 1985-03-18
FI64594C (fi) 1983-12-12
YU44212B (en) 1990-04-30

Similar Documents

Publication Publication Date Title
IT1105040B (it) 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati
IT1100185B (it) 1,4-di-idro-piridine nitro-sostituite,procedimenti per la loro preparazione e loro impiego come prodotti medicinali
IT1160853B (it) Derivati di feniletanolammina,particolarmente utili in terapia,e procedimento per la loro preparazione
IT7852280A0 (it) Procedimento per la produzione di derivati ammidici in particolare acilanilidi sostituite e prodotto ottenuto
IT7850335A0 (it) Procedimento per la preparazione di naftiridinoni sostituiti e prodotto ottenuto
IT8067134A0 (it) Derivati dell alcool benzilico particolarmente utili come antidiabetici e procedimento per la loro preparazione
IT7849891A0 (it) Procedimento per la produzione di derivati ciclopropanici prodotto ottenuto e suo impiego nella preparazione di derivati ciclopropanici con catena dialogenovinilica
IT1094916B (it) N-eterocicli n-fenil-sostituiti,loro preparazione e loro impiego in prodotti per influire sulla crescita delle piante
IT1108121B (it) Derivati di fenilisotiocianati particolarmente utili come fungicidi per agricoltura e procedimento per la loro preparazione
IT7867583A0 (it) Preparato per la profilassi e la terapia dell acne
IT1097644B (it) Derivati del 1,3-difenossipropano processo per la loro preparazione e loro impiego come medicinali
IT1123756B (it) Procedimento per la fabbricazione continua di pannelli,in particolare di pannelli di masonite
IT1097897B (it) Derivati del piranocromone e composizione terapeutica comprendente gli stessi,per il trattamento di malattie allergiche
IT1094215B (it) Pirrolo chinossalinoni e pirrolo benzodiazepinoni utili come agenti antiinfiammatori e antitrombotici e procedimento per prepararli
IT1099056B (it) 1,4-di-idro-piridazine,procedimento per la loro preparazione e loro impiego come prodotti medicinali
IT1153794B (it) Istamicine e produzione delle stesse, per impiego come antibatterici ed antibictici
IT1109653B (it) Derivati del tetraidro 1 3 5 tiadiazin 4 one particolarmente utili come insetticidi e procedimento per la loro preparazione
IT1105048B (it) Catalizzatore di titano solido e procedimento per produrlo ed applicarlo
IT7848192A0 (it) Procedimento per la produzione di derivati di 9-2-idrossietossimetilguanina e prodotto ottenuto
IT7850963A0 (it) Procedimento per la preparazione di chinazoline tricicliche e prodotto ottenuto
IT1109342B (it) Procedimento di preparazione di tieno 2,3-c-e 3,2-c piridine prodotti ottenuti e loro applicazione terapeutica
IT7967037A0 (it) Derivati delle 3 alcossicarbonildiazepine particolarmente utili in terapia e procedimento per la loro preparazione
IT1110876B (it) Procedimento per la preparazione di 1-idrossiaporfin derivati e prodotto ottenuto
IT1108089B (it) Prodotto per promuovere la crescita delle piante
IT1093702B (it) 2,4-diclorofenti-imidazolil-etanoni (oli),procedimento per la loro preparazione e loro impiego come prodotti medicinali

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530